From: Implication of species change of Nontuberculous Mycobacteria during or after treatment
Patients, No. | N = 16 |
---|---|
Age, years, median (IQR) | 69 (61.7-73.5) |
Sex, female | 12 (75.0%) |
BMI, kg/m2, median (IQR) | 20.8 (19.2-21.4) |
Never smoker | 14 (87.5%) |
History of tuberculosis | 6 (37.5%) |
Underlying disease | |
Connective tissue disease | 4 (25.0%) |
Diabetes | 3 (18.7%) |
Malignancy | 1 (6.0%) |
Respiratory symptoms | |
Sputum | 16 (100%) |
Cough | 13 (81.2%) |
Dyspnea | 4 (25.0%) |
Hemoptysis | 3 (18.7%) |
General symptoms | |
Weight loss | 2 (12.5%) |
Night sweating | 1 (6.2%) |
Laboratory findings, median (IQR) | |
Leukocytes (×103/μl) | 6880 (5070-7542) |
Hemoglobin (g/dl) | 12.6 (11.9-13.3) |
Cholesterol | 168 (149-187.7) |
Albumin | 4 (3.8-4.4) |
Creatinine | 0.7 (0.6-0.9) |